高血压联盟与转化医学_刘力生演示文稿.ppt

Survey of hyperTensive pAtienTs blood pressUre control rate in clinic Service 两大权威机构联合发起并主办 总结 三甲医院心血管科、肾内科、内分泌科门诊高血压患者 血压140/90mmHg达标率为45.1% 糖尿病或肾病患者血压(130/80mmHg)和其他患者 （140/90mmHg）血压达标率为31.1% 最常见的合并疾病依次为血脂异常(43.2%)、糖尿病(37.1%)、冠心病(22.6%)及肾功能不全(18.3%) 高血压联盟与转化医学 刘力生 Purpose of WHL To develop or promote health by educating and instructing health care professionals and the public on preventative and curative measures for hypertension. 对专业人员和群众进行?健康促进教育 To promote and conduct research related to the prevention and treatment of hypertension 促进和组织防治高血压的研究项目? To promote the detection, control and prevention of hypertension in the population through joint efforts of all national leagues and societies. ?联合各国的联盟与学会促进高血压防控工作 To liaise with the national bodies, promoting the exchange of information among them, and offering internationally applicable methods and programs for hypertension control. 与各国家团体联系,交流提供有关控制高血压的国际可行的方法与计划. Chronic Disease in China-2007 CVD Report of China中国慢病现状 New onset stroke: 2million/yr，Survived stroke:13 million CVD patients: 230 million New onset MI: 0.5 million，survived MI: 3 million；CHD: 8 milllion Patients with chronic diseases in 2003: 574 million ： DM: 33 million-- Cancer: 46 million Cerebrovascular diseases: 93 million Cardiac disease: 165 million Hypertension: 237 million Trials Year Contributions Syst.-China Chinese Systolic HT in the Elderly Trial 1998 Total mortality, CVD mortality Stroke mortality reduced by CCB based treatment in isolated systolic HT pts PATs Post Stroke Anti HT Treatment Study 1996 BP reduction in post stroke pts. Reduced stroke recurrence , even in normotensive STONE Antihypertensive tr.in elderly CCB effective in stroke reduction in elder hypertensives FEVER Chinese Felodipine Event Reduction Trial 2004 More or less antihypertensive treatment on stroke Hypertension Clinical Trials in China Trials Year Con